Cutler Group LP Apellis Pharmaceuticals, Inc. Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Cutler Group LP holds 9,700 shares of APLS stock, worth $197,200. This represents 0.02% of its overall portfolio holdings.

Number of Shares

9,700

Previous 10,201 4.91%

Holding current value

$197,200

Previous $610,000 90.98%

% of portfolio

0.02%

Previous 0.05%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$37.14 - $64.82 $999,845 - $1.75 Million	-26,921 Reduced 72.52%	10,201 $610,000
Q3 2023 Nov 07, 2023	BUY	$23.65 - $89.22 $859,511 - $3.24 Million	36,343 Added 4665.34%	37,122 $1.41 Million
Q2 2023 Jul 18, 2023	SELL	$76.68 - $93.31 $208,646 - $253,896	-2,721 Reduced 77.74%	779 $70,000
Q1 2023 May 01, 2023	BUY	$46.59 - $66.96 $150,252 - $215,945	3,225 Added 1172.73%	3,500 $230,000
Q4 2022 Feb 07, 2023	BUY	$43.24 - $61.04 $7,567 - $10,682	175 Added 175.0%	275 $14,000
Q3 2022 Oct 25, 2022	SELL	$44.76 - $69.66 $463,847 - $721,886	-10,363 Reduced 99.04%	100 $6,000
Q2 2022 Aug 04, 2022	BUY	$35.07 - $59.21 $287,574 - $485,522	8,200 Added 362.35%	10,463 $473,000
Q1 2022 Apr 14, 2022	SELL	$35.46 - $54.12 $107,443 - $163,983	-3,030 Reduced 57.25%	2,263 $114,000
Q4 2021 Jan 18, 2022	SELL	$30.74 - $49.16 $2.97 Million - $4.74 Million	-96,492 Reduced 94.8%	5,293 $250,000
Q3 2021 Oct 26, 2021	BUY	$31.4 - $69.84 $3.11 Million - $6.91 Million	98,985 Added 3535.18%	101,785 $3.35 Million
Q2 2021 Jul 19, 2021	BUY	$40.9 - $64.9 $81,800 - $129,800	2,000 Added 250.0%	2,800 $176,000
Q1 2021 Apr 26, 2021	BUY	$40.8 - $57.39 $20,400 - $28,695	500 Added 166.67%	800 $34,000
Q4 2020 Jan 21, 2021	SELL	$30.79 - $57.2 $52,343 - $97,240	-1,700 Reduced 85.0%	300 $17,000
Q2 2020 Jul 22, 2020	SELL	$24.8 - $38.49 $94,240 - $146,262	-3,800 Reduced 65.52%	2,000 $65,000
Q1 2020 May 07, 2020	BUY	$17.91 - $44.33 $53,730 - $132,990	3,000 Added 107.14%	5,800 $155,000
Q3 2019 Oct 28, 2019	BUY	$24.09 - $32.18 $67,452 - $90,104	2,800 New	2,800 $67,000

Others Institutions Holding APLS

# of Institutions

330

Shares Held

124M

Call Options Held

4.15M

Put Options Held

769K

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $2.23B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account